Fate Therapeutics (FATE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -103,941 | -71,691 | -37,621 | -186,262 | -134,109 |
| Depreciation Amortization | 7,113 | 4,696 | 2,265 | 9,882 | 6,599 |
| Accounts receivable | 2,857 | 2,144 | 1,134 | -1,113 | -1,701 |
| Other Working Capital | -4,796 | -5,300 | -5,373 | -1,958 | -49 |
| Other Operating Activity | 15,997 | 11,755 | 5,786 | 56,577 | 34,185 |
| Operating Cash Flow | $-82,770 | $-58,396 | $-33,809 | $-122,874 | $-95,075 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 88,172 | 64,700 | 43,869 | 12,948 | -9,966 |
| PPE Investments | -4,636 | -2,436 | -1,196 | -730 | -632 |
| Investing Cash Flow | $83,536 | $62,264 | $42,673 | $12,218 | $-10,598 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 94,822 | 94,822 |
| Other Financing Activity | 3,800 | 1,325 | 0 | 5,070 | 1,940 |
| Financing Cash Flow | $3,800 | $1,325 | $N/A | $99,892 | $96,762 |
| Beginning Cash Position | 46,283 | 46,283 | 46,283 | 57,047 | 57,047 |
| End Cash Position | 50,849 | 51,476 | 55,147 | 46,283 | 48,136 |
| Net Cash Flow | $4,566 | $5,193 | $8,864 | $-10,764 | $-8,911 |
| Free Cash Flow | |||||
| Operating Cash Flow | -82,770 | -58,396 | -33,809 | -122,874 | -95,075 |
| Capital Expenditure | -4,761 | -2,558 | -1,196 | -730 | -632 |
| Free Cash Flow | -87,531 | -60,954 | -35,005 | -123,604 | -95,707 |